Solving the 30-Year Old Mystery of How Resistance Genes Spread
News Jun 19, 2017 | Original story from Technical University of Denmark
Actinomycetes on a plate. Credit: DTU/DTU Biosustain
Scientists have revealed that certain disease-causing bacteria get their resistance genes in a complex process involving bacterial ‘sex’. This new knowledge can potentially lead to a more targeted effort in counteracting the spread of antibiotic resistance
To win the war against antibiotic-resistant superbugs, scientists seek to find the origin of resistance genes. Further, they try to identify how the genes are introduced to disease-causing bacteria – so-called pathogens. Identifying where resistance genes come from and how they spread somewhat compares to finding patient zero in an outbreak, which is not an easy task.
For more than 30 years, scientists have proposed that resistance genes actually originate from the microorganisms producing the antibiotic. But even though this has been a hypothesis, scientists have not been able to find direct proof of this transfer.
Now, research conducted at The Novo Nordisk Foundation Center for Biosustainability – DTU Biosustain – at Technical University of Denmark for the very first time shows that antibiotic resistance genes originate from the same place as the antibiotic compounds, i.e. from a group of soil bacteria called Actinobacteria.
The study is now published in Nature Communications
Actinobacteria as a source of antibiotic resistance genes
More than three fourths of all current antibiotics used to treat human infections are produced by Actinobacteria, which at the same time carry antibiotic resistance genes.
In these experiments, the researchers surprisingly found that many resistance genes in disease-causing microbes (gram negative pathogens) were very similar to resistance genes found in Actinobacteria. Especially in one case, the genes were 100% identical.
“It has been suspected that pathogens can obtain resistance genes from Actinobacteria for half a century. So now with the 100 % identical genes we find the smoking gun,” says Postdoc Xinglin Jiang from DTU Biosustain.
Gram negative pathogens constitute a big group of different species; amongst others pseudomonas, which can cause lung and urinary tract infections.
A new mechanism mediating the resistance gene transfer
At first, it was difficult to imagine how pathogens can acquire genes from Actinobacteria, because they are so different and not at all related with each other. But by investigating the DNA sequence around the resistance genes, the team figured out how the resistance genes transfer occurred through a new mechanism named “carry back”, where the pathogen basically has a primitive form of “sex” with the Actinobacterium and takes up its resistance genes after it dies.
This gene transfer by carry back could in principle happen where pathogens come into contact with Actinobacteria, like in an animal farm or in soil polluted with untreated hospital waste. In this way, the pathogen can become resistant and endanger human lives in the next round of infection.
Understanding the origin is hence key to counteracting the spread of antibiotic resistance, explains Senior Researcher Tilmann Weber from DTU Biosustain:
“We can’t stop this gene transfer, but when you know, which resistance genes pathogens may harbor, you can personalize the antibiotic treatment. Also, with this knowledge you can try to develop new antibiotics with other properties that the pathogens don’t have a defense against.”
This article has been republished from materials provided by Technical University of Denmark. Note: material may have been edited for length and content. For further information, please contact the cited source.
Jiang, X., Ellabaan, M. M. H., Charusanti, P., Munck, C., Blin, K., Tong, Y., ... & Lee, S. Y. (2017). Dissemination of antibiotic resistance genes from antibiotic producers to pathogens. Nature communications, 8, 15784.
In treating inflammatory bowel disease (IBD), physicians can have a hard time telling which newly diagnosed patients have a high risk of severe inflammation or what therapies will be most effective. Now researchers report finding an epigenetic signature in patient cells that appears to predict inflammation risk in a serious type of IBD called Crohn’s disease.